Literature DB >> 10435494

Factor analysis of the motor section of the unified Parkinson's disease rating scale during the off-state.

G T Stebbins1, C G Goetz, A E Lang, E Cubo.   

Abstract

Determination of a scale's factor structure requires a two-part process: (1) an initial examination of the factor structure using a sample of individuals with the condition of interest, and (2) repeated examinations of the factor structure using the same analytic methods but applied to independent samples of individuals with the condition of interest who contribute unique variability to the scale measurement. In a previous study, we performed an initial investigation of the factor structure of the Motor Examination section of the Unified Parkinson's Disease Rating Scale (UPDRS). We used a sample of 294 consecutive patients with idiopathic Parkinson's disease (PD) assessed while in the on-state and identified six clinically distinct factors. In the present study, we performed a confirmatory investigation of the factor structure and analysis of the internal consistency of the UPDRS in a new sample of 200 consecutive PD patients who were assessed while in the off-state. Factor analysis again revealed six factors with identical item loadings as those obtained from examinations of patients in the on-state. Estimates of internal consistency were comparable in the off- and on-state examinations. These results indicate that the Motor Examination section of the UPDRS has a stable factor structure and high internal consistency across off- and on-state examinations.

Entities:  

Mesh:

Year:  1999        PMID: 10435494     DOI: 10.1002/1531-8257(199907)14:4<585::aid-mds1006>3.0.co;2-3

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  18 in total

1.  Blood oxygenation level-dependent activation in basal ganglia nuclei relates to specific symptoms in de novo Parkinson's disease.

Authors:  Janey Prodoehl; Mathew Spraker; Daniel Corcos; Cynthia Comella; David Vaillancourt
Journal:  Mov Disord       Date:  2010-10-15       Impact factor: 10.338

2.  The impact of subthalamic deep brain stimulation on bradykinesia of proximal and distal upper limb muscles in Parkinson's disease.

Authors:  Manuel Dafotakis; Gereon R Fink; Niels Allert; Dennis A Nowak
Journal:  J Neurol       Date:  2008-03-19       Impact factor: 4.849

Review 3.  Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report.

Authors:  Deborah A Hall; Maria João Forjaz; Lawrence I Golbe; Irene Litvan; Christine Ann M Payan; Christopher G Goetz; Albert F G Leentjens; Pablo Martinez-Martin; Anne Pavy-Le Traon; Cristina Sampaio; Bart Post; Glenn Stebbins; Daniel Weintraub; Anette Schrag
Journal:  Mov Disord Clin Pract       Date:  2015-05-22

4.  Erythropoietin inhibits HIF-1α expression via upregulation of PHD-2 transcription and translation in an in vitro model of hypoxia-ischemia.

Authors:  Rhonda Souvenir; Jerry J Flores; Robert P Ostrowski; Anatol Manaenko; Kamil Duris; Jiping Tang
Journal:  Transl Stroke Res       Date:  2013-11-27       Impact factor: 6.829

5.  Predictors of health status in nondepressed and nondemented individuals with Parkinson's disease.

Authors:  Dawn M Schiehser; S Duke Han; Stephanie Lessig; David D Song; Vanessa Zizak; J Vincent Filoteo
Journal:  Arch Clin Neuropsychol       Date:  2009-09-18       Impact factor: 2.813

6.  Treatment benefit and daily drug costs associated with treating Parkinson's disease in a Parkinson's disease clinic.

Authors:  Thomas Müller; Birgit Voss; Kerstin Hellwig; Franz Josef Stein; Thorsten Schulte; Horst Przuntek
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

7.  Dopamine replacement therapy does not restore the ability of Parkinsonian patients to make rapid adjustments in motor strategies according to changing sensorimotor contexts.

Authors:  E Tunik; A G Feldman; H Poizner
Journal:  Parkinsonism Relat Disord       Date:  2007-04-18       Impact factor: 4.891

8.  Progression of MDS-UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort.

Authors:  Samantha K Holden; Taylor Finseth; Stefan H Sillau; Brian D Berman
Journal:  Mov Disord Clin Pract       Date:  2017-09-22

9.  Confirmatory factor analysis of the motor unified Parkinson's disease rating scale.

Authors:  Stefanie D Vassar; Yvette M Bordelon; Ron D Hays; Natalie Diaz; Rebecca Rausch; Cherry Mao; Barbara G Vickrey
Journal:  Parkinsons Dis       Date:  2012-10-22

10.  Assessing bradykinesia in parkinsonian disorders.

Authors:  Gian Pal; Christopher G Goetz
Journal:  Front Neurol       Date:  2013-06-03       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.